Associated Press: Johnson & Johnson Ebola groups get $117M in funding
“Johnson & Johnson is working with a slew of organizations to speed up development of an Ebola vaccine, and the company said Friday that a European health organization awarded them $117 million…” (1/16).

Financial Times: J&J receives €100m E.U. injection for Ebola vaccine development
“J&J and its partners are the main beneficiaries of a €215m funding package from the E.U.-backed Innovative Medicines Initiative announced on Friday to support development and manufacturing of vaccines and diagnostic tools for Ebola…” (Ward, 1/16).

Wall Street Journal: J&J Gets Grant to Speed Up Ebola Vaccine
“…The grants will go toward clinical trials and production of J&J’s experimental vaccine and a campaign to raise awareness of the vaccination. In October, J&J committed $200 million to developing the treatment and has since been looking for funding partners…” (Dulaney, 1/16).